King B, Soung J, Tziotzios C, Rudnicka L, Joly P, Gooderham M, Sinclair R, Anway S, Wajsbrot D, Lejeune A, Zwillich S. Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s291. Available from: https://jofskin.org/33014/index.php/skin/article/view/2417